The absence of anti-tumor activity of anti-PDL2, anti-CTLA4 and combination of anti-PDL1 and anti-CTLA4 further demonstrated that ICIs alone were unable to induce a robust immune response. The gene discussed is CTLA4; the disease is neoplasm.